A5056796828- Monoclonal and Polyclonal Antibodies Research
- Advanced Biosensing Techniques and Applications
- Neutropenia and Cancer Infections
- Genetics, Bioinformatics, and Biomedical Research
- Glycosylation and Glycoproteins Research
- Hematopoietic Stem Cell Transplantation
- Virus-based gene therapy research
- Advanced biosensing and bioanalysis techniques
- RNA and protein synthesis mechanisms
- Computational Drug Discovery Methods
- Viral Infectious Diseases and Gene Expression in Insects
- RNA Interference and Gene Delivery
- Acute Lymphoblastic Leukemia research
- Chronic Lymphocytic Leukemia Research
University of Leeds
2017-2024
Molecular recognition reagents are key tools for understanding biological processes and used universally by scientists to study protein expression, localisation interactions. Antibodies remain the most widely of such many show excellent performance, although some poorly characterised or have stability batch variability issues, supporting use alternative binding proteins as complementary applications. Here we report on Affimer research reagents. We selected 12 diverse molecular targets...
Monoclonal antibodies, renowned for their efficacy as cancer therapies, both standalone agents and in conjunction with cytotoxic payloads, are experiencing a transformative shift. Non-immunoglobulin scaffolds compelling alternatives to monoclonal the precise delivery of cargo into cell lines. With focus on HER2, frequently overexpressed receptor breast cancer, this study addresses some limitations conventional targeting moieties, by harnessing potential alternative binding reagents....